As Pharma Prices Continue To Rise, So Does CEO Pay

As prescription drug prices continue to rise, so does CEO pay. The 25 highest paid CEOs are listed below.

CEOCompanyTotal Pay
Ari BousbibIqvia Holdings$38,029,517
Brenton SaundersAllergan$32,827,626
Alex GorskyJohnson & Johnson$29,802,564
Ian ReadPfizer Inc$27,913,775
Leonard SchleiferRegeneron $26,508,058
Richard GonzalezAbbvie$22,625,243
Marc CasperThermo Fisher $22,275,176
Giovanni CaforioBristol Myers Squibb$18,687,123
Howard RobinNektar Therapeutics$18,097,411
Kenneth FrazierMerck $17,643,087
Jeffrey LeidenVertex $17,227,301
Robert BradwayAmgen$16,899,789
Herve HoppenotIncyte$16,087,031
Ricks DavidEli Lilly$15,845,991
John MulliganGilead Sciences$15,438,459
Michel VounatsosBiogen$13,664,373
Mark AllesCelgene$13,115,985
Heather BreschMylan$12,744,397
Robert FrielPerkinelmer$11,365,597
Juan Ramon AlaixZoetis$10,528,769
Michael McMullenAgilent Technologies$10,090,661
Francis DesouzaIllumina$8,807,716
John HendricksonPerrigo$8,322,228
Christopher O’ConnellWaters Corp$7,599,988
Oliver FilliolMettler Toledo$7,259,085

Author: jhyman@jeffhyman.net

Jeff Hyman is a recognized and respected insurance executive with a proven track record of developing and leading the execution of business plans and sales strategies that delivers growth and bottom line results through strategic thinking, innovative problem-solving, and customized solutions.

Leave a Reply

Your email address will not be published. Required fields are marked *